Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 18/20 | 0.69 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.67 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL932572 | 1.00 | BACE1 (0.69) | BACE1KCNH2BACE2ACHERELA | |
| SCHEMBL932706 | 0.87 | BACE1 (0.66) | BACE1KCNH2BACE2CTSD | |
| SCHEMBL933032 | 0.86 | BACE1 (0.79) | BACE1KCNH2BACE2CTSD | |
| SCHEMBL931913 | 0.84 | BACE1 (0.62) | BACE1KCNH2BACE2 | |
| SCHEMBL932620 | 0.82 | BACE1 (1.00) | BACE1KCNH2BACE2CTSD | |
| SCHEMBL931912 | 0.82 | BACE1 (1.00) | BACE1KCNH2BACE2CTSD | |
| SCHEMBL932522 | 0.81 | BACE1 (1.00) | BACE1KCNH2BACE2CTSD | |
| SCHEMBL6920585 | 0.80 | BACE1 (0.80) | BACE1KCNH2BACE2 | |
| SCHEMBL932233 | 0.76 | BACE1 (1.00) | BACE1KCNH2BACE2CTSD | |
| SCHEMBL932644 | 0.76 | BACE1 (0.73) | BACE1KCNH2BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011002407-A1 | NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA | ASTRAZENECA AB (SE) | 2011-01-06 | — | — | WO | disclosed |